Sveriges mest populära poddar
Exchanges
Näringsliv

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

27 min•7 november 2023
Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond. Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt av Exchanges

Visa alla avsnitt av Exchanges
Why Aren’t Investors More Worried?
•20 min
Natural Gas in Focus: Iran Conflict Could Have ‘Very Painful’ Consequences
•16 min
AI Exchanges: Power Problems?
•20 min
The Business Builder: New Mountain Capital's Steve Klinsky
•35 min
Iran Conflict: How Long, and How Bad?
•20 min
Private Credit Concerns in Context
•31 min
Lloyd Blankfein on His Memoir Streetwise, Risk Management and Leadership
•31 min
Emerging Markets: Stirred, But Not Yet Shaken
•15 min
Goldman Sachs International’s Co-CEOs on Europe’s Opportunity, AI, and Market Volatility
•27 min
Can Software Survive AI?
•15 min

Exchanges med Goldman Sachs finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.